Effects of hydrogen peroxide, nitric oxide and antioxidants on NF-κB

REFERENCES

• Baeuerle P A, Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 1988; 53: 211–217.
   PubMed Web of Science ®Google Scholar
• Baeuerle P A. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072: 63–80.
   PubMed Web of Science ®Google Scholar
• Baeuerle P A, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141–179.
   PubMed Web of Science ®Google Scholar
• Du W, Thanos D, Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 1993; 74: 887–898.
   PubMed Web of Science ®Google Scholar
• Finco T S, Baldwin A S Jr. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J Biol Chem 1993; 268: 17676–17679.
   PubMed Web of Science ®Google Scholar
• Kowalik T F, Wing B, Haskill J S, Azizkhan J C, Baldwin A S Jr, Huang E S. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 1993; 90: 1107–1111.
   PubMed Web of Science ®Google Scholar
• Betts J C, Agranoff A B, Nabel G J, Shayman J A. Dissociation of endogenous cellular ceramide from NF-kappa B activation. J Biol Chem 1994; 269: 8455–8458.
   PubMed Web of Science ®Google Scholar
• Nabel G J. HIV. Tampering with transcription [news; comment]. Nature 1991; 350: 658.
   PubMed Web of Science ®Google Scholar
• Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405–455.
   PubMedGoogle Scholar
• Link E, Kerr L D, Schreck R, Zabel U, Verma I, Baeuerle P A. Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem 1992; 267: 239–246.
   PubMed Web of Science ®Google Scholar
• Finco T S, Beg A A, Baldwin A S Jr. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 1994; 91: 11884–11888.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 1990; 344: 678–682.
   PubMed Web of Science ®Google Scholar
• Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle P A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993; 365: 182–185.
   PubMed Web of Science ®Google Scholar
• Perkins N D, Schmid R M, Duckett C S, Leung K, Rice N R, Nabel G J. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci USA 1992; 89: 1529–1533.
   PubMed Web of Science ®Google Scholar
• Meyer M, Pahl H L, Baeuerle P A. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact 1994; 91: 91–100.
   PubMed Web of Science ®Google Scholar
• Schreck R, Rieber P, Baeuerle P A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247–2258.
   PubMed Web of Science ®Google Scholar
• Meyer M, Schreck R, Baeuerle P A. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12: 2005–2015.
   PubMed Web of Science ®Google Scholar
• Staal F J, Roederer M, Herzenberg L A, Herzenberg L A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990; 87: 9943–9947.
   PubMed Web of Science ®Google Scholar
• Kalebic T, Kinter A, Poli G, Anderson M E, Meister A, Fauci A S. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N- acetylcysteine. Proc Natl Acad Sci USA 1991; 88: 986–990.
   PubMed Web of Science ®Google Scholar
• Menon S D, Qin S, Guy G R, Tan Y H. Differential induction of nuclear NF-kappa B by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation. J Biol Chem 1993; 268: 26805–26812.
   Google Scholar
• Israel N, Gougerot-Pocidalo M A, Aillet F, Virelizier J L. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 1992; 149: 3386–3393.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Ueno Y, Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 1993; 268: 11380–11388.
   PubMed Web of Science ®Google Scholar
• Kumar S, Rabson A B, Gelinas C. The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Reloncoprotein. Mol Cell Biol 1992; 12: 3094–3106.
   PubMed Web of Science ®Google Scholar
• Anderson M T, Staal F J, Gitler C, Herzenberg L A, Herzenberg L A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc Natl Acad Sci USA 1994; 91: 11527–11531.
   PubMed Web of Science ®Google Scholar
• Meshnick S R. Free radicals and antioxidants [letter]. Lancet 1994; 344: 1441–1442.
   PubMed Web of Science ®Google Scholar
• Perkins N D, Edwards N L, Duckett C S, Agranoff A B, Schmid R M, Nabel G J. A cooperative interaction between NF-kappa B and Spl is required for HIV-1 enhancer activation. EMBO J 1993; 12: 3551–3558.
   PubMed Web of Science ®Google Scholar
• Liu J, Perkins N D, Schmid R M, Nabel G J. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J Virol 1992; 66: 3883–3887.
   PubMed Web of Science ®Google Scholar
• Leung K, Nabel G J. HTLV-I transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 1988; 333: 776–778.
   PubMed Web of Science ®Google Scholar
• Marletta M A. Nitric oxide, nitrovasodilators, and L-arginine—an unusual relationship [editorial]. West J Med 1991; 154: 107–109.
   PubMedGoogle Scholar
• Halliwell B, Gutteridge J M C. In: Free Radicals in Biology and Medicine, 2nd ed. Oxford: Clarendon Press, 1989.
   Google Scholar
• Adcock I M, Brown C R, Kwon O, Barnes P J. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199: 1518–1524.
   PubMed Web of Science ®Google Scholar
• Jarstrand C, Akerlund B. Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individuals. Chem Biol Interact 1994; 91: 147–158.
   PubMed Web of Science ®Google Scholar
• Sonnerborg A, Carlin G, Akerlund B, Jarstrand C. Oxidative stress, HIV and AIDS. Res Immunol 1992; 143: 145–148.
   PubMedGoogle Scholar
• Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994; 91: 165–180.
   PubMed Web of Science ®Google Scholar
• Matthews J R, Wakasugi N, Virelizier J L, Yodoi J, Hay R T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 1992; 20: 3821–3830.
   PubMed Web of Science ®Google Scholar
• Muroi M, Muroi Y, Suzuki T. A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects. J Acquir Immune Defic Syndr 1994; 7: 369–374.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin Chim Acta 1994; 230: 35–42.
   PubMed Web of Science ®Google Scholar
• Dudley J, Jin S, Hoover D, Metz S, Chmiel J, Thackery R. Follow-up of the Multicenter AIDS Cohort Study (MACS) after 6 years. International Conference on AIDS 1993; 9: 657 (abstract no. PO-C04-2640).
   Google Scholar
• Hersh E M, Brewton G, Abrams D et al. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study [see comments], JAMA 1991; 265: 1538–1544.
   Google Scholar
• Fuchs J, Janka S, Ochsendorf F et al. Oxidants and antioxidants in HIV infected patients. International Conference on AIDS 1991; 7: 223 (abstract no. W.B.2166).
   Google Scholar
• Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Selenium in the maintenance and therapy of HIV-infected patients (published erratum appears in Chem Biol Interact 1995 Feb; 94(2): 167). Chem Biol Interact 1994; 91: 199–205.
   Web of Science ®Google Scholar
• Raju P A, Herzenberg L A, Herzenberg L A, Roederer M. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication. AIDS Res Hum Retroviruses 1994; 10: 961–967.
   PubMed Web of Science ®Google Scholar
• Griffin G E, Leung K, Folks T M, Kunkel S, Nabel G J. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B [see comments]. Nature 1989; 339: 70–73.
   PubMed Web of Science ®Google Scholar
• Staal F J, Ela S W, Roederer M, Anderson M T, Herzenberg L A, Herzenberg L A. Glutathione deficiency and human immunodeficiency virus infection [see comments]. Lancet 1992; 339: 909–912.
   PubMed Web of Science ®Google Scholar
• Simon G, Moog C, Obert G. The Place of Oxygen Free Radicals in HIV Infections. Proceedings of a conference. Les Deux Alpes, France, January 1993. Chem Biol Interact 1994; 91: 77–224.
   Google Scholar
• Harakeh S, Jariwalla R J. Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells. Am J Clin Nutr 1991; 1231S–1235S.
   Google Scholar
• Xie Q W, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705–4708.
   PubMed Web of Science ®Google Scholar
• Stamler J S, Singel D J, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms [see comments]. Science 1992; 258: 1898–1902.
   PubMed Web of Science ®Google Scholar
• Sinichkin A A, Polyak A I, Kirsanova O N. Downregulation of ADF/human thioredoxin as a possible mediator of HIV-induced apoptosis. International Conference on AIDS 1994; 10: 95 (abstract no. PA0262).
   Google Scholar
• Lander H M, Sehajpal P K, Novogrodsky A. Nitric oxide signaling: a possible role for G proteins. J Immunol 1993; 151: 7182–7187.
   PubMed Web of Science ®Google Scholar